Alison J. Smith

1.8k citations

30 papers · 1.3k indexed · 1 hit paper · h-index 16

Cellular and Molecular Neuroscience top 2%
Molecular Biology
Cognitive Neuroscience top 5%
Organic Chemistry top 10%
Physiology

Co-authors: Ruth M. McKernan John Atack George Marshall Thomas W. Rosahl Neil Collinson Frederick M. Kuenzi Wolfgang Jarolimek Owain W. Howell
Topics: Neuroscience and Neuropharmacology Research (17 papers)Pharmacological Receptor Mechanisms and Effects (8 papers)Neuropeptides and Animal Physiology (8 papers)
Cited by: Cellular and Molecular Neuroscience Behavioral Neuroscience Biological Psychiatry
Journals: Journal of Neuroscience Journal of Medicinal Chemistry The Journal of Infectious Diseases
Partner nations: United States United Kingdom Australia

In The Last Decade

Alison J. Smith

29 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhanced Learning and Memory and Altered GABAergic Synaptic Transmission in Mice Lacking the α5 Subunit of the GABA_AReceptor

2002 509 citations Alison J. Smith, John Atack et al. profile →

Peers

Countries citing papers authored by Alison J. Smith

Since Specialization

Citations

This map shows the geographic impact of Alison J. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. Smith more than expected).

Fields of papers citing papers by Alison J. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. Smith. The network helps show where Alison J. Smith may publish in the future.

Co-authorship network of co-authors of Alison J. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Alison J. Smith. A scholar is included among the top collaborators of Alison J. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison J. Smith. Alison J. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Concordance of CCR5 Genotypes that Influence Cell-Mediated Immunity and HIV-1 Disease Progression Rates 2010 ·The Journal of Infectious Diseases ·Gabriel Catano,(unknown),(unknown),Juan‐Manuel Anaya,Weijing He,Alison J. Smith,Rosa Bologna,(unknown),Robert A. Clark,Andrew R. Lloyd,(unknown),Sunil K. Ahuja	21
2	2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: Functionally selective GABAA α3-subtype agonists 2006 ·Bioorganic & Medicinal Chemistry Letters ·Robert W. Carling,Michael G. N. Russell,Kevin W. Moore,(unknown),(unknown),Alison J. Smith,Keith A. Wafford,George Marshall,John Atack,Leslie J. Street	12
3	Pyrazolopyridinones as functionally selective GABAA ligands 2005 ·Bioorganic & Medicinal Chemistry Letters ·Wesley Blackaby,John Atack,Frances A. Bromidge,Richard Lewis,Michael G. N. Russell,Alison J. Smith,Keith A. Wafford,Ruth M. McKernan,Leslie J. Street,José L. Castro	15
4	Tricyclic pyridones as functionally selective human GABAAα2/3 receptor-ion channel ligands 2004 ·Bioorganic & Medicinal Chemistry Letters ·James Crawforth,John Atack,Susan M. Cook,Karl R. Gibson,Alan Nadin,Andrew P. Owens,Andrew Pike,Michael Rowley,Alison J. Smith,Bindi Sohal,Francine Sternfeld,Keith A. Wafford,Leslie J. Street	11
5	Influences of Distress and Alcohol Consumption on the Development of a Delayed-Type Hypersensitivity Skin Test Response 2004 ·Psychosomatic Medicine ·Alison J. Smith,Uté Vollmer‐Conna,Barbara Bennett,Ian B. Hickie,Andrew R. Lloyd	19
6	2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptor 2004 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),John Atack,Peter Blurton,Robert W. Carling,José L. Castro,(unknown),Michael G. N. Russell,George Marshall,Ruth M. McKernan,Kevin W. Moore,Robert Narquizian,Alison J. Smith,Leslie J. Street,(unknown),Keith A. Wafford	18
7	Multiple structural features of steroids mediate subtype-selective effects on human α4β3δ GABAA receptors 2004 ·Biochemical Pharmacology ·Gopalan V. Pillai,Alison J. Smith,Peter Hunt,Peter B. Simpson	12
8	Does genotype mask the relationship between psychological factors and immune function? 2004 ·Brain Behavior and Immunity ·Alison J. Smith,Uté Vollmer‐Conna,Andrew F. Geczy,H. Dunckley,Barbara Bennett,Ian B. Hickie,Andrew R. Lloyd	5
9	The relationship between distress and the development of a primary immune response to a novel antigen 2003 ·Brain Behavior and Immunity ·Alison J. Smith,Uté Vollmer‐Conna,Barbara Bennett,Denis Wakefield,Ian B. Hickie,Andrew R. Lloyd	37
10	Effect of α Subunit on Allosteric Modulation of Ion Channel Function in Stably Expressed Human Recombinant γ-Aminobutyric Acid_AReceptors Determined Using³⁶Cl Ion Flux 2001 ·Molecular Pharmacology ·Alison J. Smith,(unknown),Jonathan D. Silk,Charles Adkins,Alan E. Fletcher,(unknown),Julie Kerby,George Marshall,Keith A. Wafford,Ruth M. McKernan,John Atack	111
11	γ-Aminobutyric Acid Type B Receptors with Specific Heterodimer Composition and Postsynaptic Actions in Hippocampal Neurons Are Targets of Anticonvulsant Gabapentin Action 2001 ·Molecular Pharmacology ·Gordon Ng,Sandrine S. Bertrand,Richard Sullivan,Nathalie Éthier,Jennifer Wang,(unknown),Michel Belley,Laird A. Trimble,Kevin P. Bateman,(unknown),Alison J. Smith,Ruth M. McKernan,Kathleen M. Metters,Gary P. O’Neill,Jean‐Claude Lacaille,Terence E. Hébert	121
12	Proliferative effects of cholecystokinin in GH₃ pituitary cells mediated by CCK₂ receptors and potentiated by insulin 1999 ·British Journal of Pharmacology ·Alison J. Smith,Ruth M. McKernan	2
13	Benzodiazepine modulation of recombinant α1β3γ2 GABAA receptor function efficacy determination using the Cytosensor microphysiometer 1998 ·European Journal of Pharmacology ·Alison J. Smith,Ruth M. McKernan,John Atack	8
14	CCk-B receptor-mediated stimulation of polyphosphoinositide turnover in gh3 pituitary cells in response to cholecystokinin and pentagastrin 1996 ·Life Sciences ·Alison J. Smith,Ben Freedman	5
15	Controlled Modification of Acidity in Cholecystokinin B Receptor Antagonists: N-(1,4-Benzodiazepin-3-yl)-N ‘-[3-(tetrazol-5-ylamino)phenyl]ureas 1996 ·Journal of Medicinal Chemistry ·José L. Castro,Richard G. Ball,Howard B. Broughton,Michael G. N. Russell,Denise Rathbone,Alan P. Watt,Raymond Baker,Kerry L. Chapman,Alan E. Fletcher,Smita S. Patel,Alison J. Smith,George Marshall,(unknown),Victor G. Matassa	59
16	Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type b receptor antagonists 1994 ·Bioorganic & Medicinal Chemistry ·Mark G. Bock,Robert M. DiPardo,(unknown),Jeffrey M. Bergman,Daniel F. Veber,Stephen B. Freedman,Alison J. Smith,Kerry L. Chapman,Smita S. Patel,John A. Kemp,George Marshall,Roger Freidinger	7
17	Second-Generation Benzodiazepine CCK-B Antagonists. Development of Subnanomolar Analogs with Selectivity and Water Solubility 1994 ·Journal of Medicinal Chemistry ·Mark G. Bock,Robert M. DiPardo,(unknown),(unknown),Daniel F. Veber,(unknown),Alison J. Smith,Smita S. Patel,John A. Kemp,George Marshall,Alan E. Fletcher,Kerry L. Chapman,Paul Anderson,Roger Freidinger	33
18	Measurement of central nervous system activity of systemically administered CCKB receptor antagonists by ex vivo binding 1994 ·European Journal of Pharmacology ·Smita S. Patel,Kerry L. Chapman,Anne Heald,Alison J. Smith,Stephen B. Freedman	23
19	Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation 1994 ·European Journal of Pharmacology Molecular Pharmacology ·Alison J. Smith,(unknown),Stephen B. Freedman	6
20	L-708,474: The C5-cyclohexyl analogue of L-365,260, a selective high affinity ligand for the CCKB/gastrin receptor 1993 ·Bioorganic & Medicinal Chemistry Letters ·Mark S. Chambers,Sarah C. Hobbs,Stephen R. Fletcher,Victor G. Matassa,Paul J. Mitchell,Alan P. Watt,Raymond Baker,Ben Freedman,Smita S. Patel,Alison J. Smith	25

About Alison J. Smith

Alison J. Smith is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Molecular Biology, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (17 papers), Pharmacological Receptor Mechanisms and Effects (8 papers) and Neuropeptides and Animal Physiology (8 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (758 citations), Behavioral Neuroscience (72 citations) and Biological Psychiatry (45 citations). Alison J. Smith has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Ruth M. McKernan, John Atack, George Marshall, Thomas W. Rosahl, Neil Collinson, Frederick M. Kuenzi, Wolfgang Jarolimek, Owain W. Howell, Guy R. Seabrook and G. R. Dawson. Their work appears in journals such as Journal of Neuroscience, Journal of Medicinal Chemistry and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact